BG Medicine, Inc. (BGMD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | 2.13 Million USD | -59.21% |
| 2014 | 5.22 Million USD | -44.09% |
| 2013 | 9.35 Million USD | -38.63% |
| 2012 | 15.24 Million USD | -41.63% |
| 2011 | 26.11 Million USD | 271.57% |
| 2010 | 7.02 Million USD | -44.34% |
| 2009 | 12.62 Million USD | -64.15% |
| 2008 | 35.21 Million USD | 0.0% |
| 2006 | 6.16 Million USD | 98.81% |
| 2005 | 3.1 Million USD | -53.54% |
| 2004 | 6.67 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2015 FY | 2.13 Million USD | -59.21% |
| 2015 Q1 | 2.59 Million USD | -50.47% |
| 2015 Q2 | 1.36 Million USD | -47.26% |
| 2015 Q3 | 3.35 Million USD | 145.68% |
| 2015 Q4 | 2.13 Million USD | -36.44% |
| 2014 Q2 | 11.24 Million USD | 82.11% |
| 2014 Q3 | 7.57 Million USD | -32.64% |
| 2014 Q4 | 5.22 Million USD | -30.93% |
| 2014 FY | 5.22 Million USD | -44.09% |
| 2014 Q1 | 6.17 Million USD | -34.01% |
| 2013 Q2 | 18.32 Million USD | -22.01% |
| 2013 FY | 9.35 Million USD | -38.63% |
| 2013 Q4 | 9.35 Million USD | -31.03% |
| 2013 Q3 | 13.56 Million USD | -25.98% |
| 2013 Q1 | 23.49 Million USD | 54.14% |
| 2012 Q4 | 15.24 Million USD | -24.35% |
| 2012 FY | 15.24 Million USD | -41.63% |
| 2012 Q1 | 31.1 Million USD | 19.15% |
| 2012 Q3 | 20.14 Million USD | -21.03% |
| 2012 Q2 | 25.51 Million USD | -17.99% |
| 2011 FY | 26.11 Million USD | 271.57% |
| 2011 Q4 | 26.11 Million USD | -13.08% |
| 2011 Q3 | 30.03 Million USD | -11.75% |
| 2011 Q2 | 34.04 Million USD | -10.47% |
| 2011 Q1 | 38.02 Million USD | 441.08% |
| 2010 Q3 | 5.96 Million USD | -19.9% |
| 2010 Q2 | 7.45 Million USD | 0.0% |
| 2010 Q4 | 7.02 Million USD | 17.72% |
| 2010 FY | 7.02 Million USD | -44.34% |
| 2009 Q4 | 12.62 Million USD | 0.0% |
| 2009 FY | 12.62 Million USD | -64.15% |
| 2008 FY | 35.21 Million USD | 0.0% |
| 2007 Q3 | 10.16 Million USD | -19.02% |
| 2007 Q2 | 12.55 Million USD | 30.34% |
| 2007 Q1 | 9.63 Million USD | 56.15% |
| 2006 Q4 | 6.16 Million USD | 0.0% |
| 2006 FY | 6.16 Million USD | 98.81% |
| 2005 FY | 3.1 Million USD | -53.54% |
| 2004 FY | 6.67 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 100.0% |
| Ansell Limited | 3.23 Billion USD | 100.0% |
| Ansell Limited | 3.24 Billion USD | 100.0% |
| Biotage AB (publ) | 488.98 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 300.36 Thousand USD | 100.0% |
| Psykey, Inc. | 1.72 Million USD | 100.0% |
| ConvaTec Group Plc | 3.7 Billion USD | 100.0% |
| ConvaTec Group Plc | 3.71 Billion USD | 100.0% |
| Encision Inc. | 3.81 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | 651.88 Thousand USD | 100.0% |
| LifePoint, Inc. | 8.8 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | 5.48 Million USD | 100.0% |
| Reflect Scientific, Inc. | 2.66 Million USD | 100.0% |
| SmileDirectClub, Inc. | 597.06 Million USD | 100.0% |
| Sector 10, Inc. | 1000.00 USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 100.0% |
| SheerVision, Inc. | 837.56 Thousand USD | 100.0% |
| United Health Products, Inc. | 284.64 Thousand USD | 100.0% |
| Vasamed, Inc. | 1.6 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | 100.0% |
| Yubo International Biotech Limited | 2.34 Million USD | 100.0% |